Buy
1
Hold
0
Sell
0
Watch
1
Mentions Over Time
last 3 months Buy Sell Hold Watch|Prediction trendFactual trend
Predictions and Factualities (2)
watchJun 3, 2026Confidence: 40%
Presenter notes NeOnc's focus on targeted brain cancer therapies using its proprietary Neo platform and intranasal delivery methods. Alliance Global set a $13 price target and Maxim set a $20 price target, implying substantial upside from $4.54. Described as an intriguing speculative opportunity with high risk but extraordinary return potential.
Target: $20Horizon: long term
buyJun 3, 2026Confidence: 40%
Presenter highlights overwhelmingly positive analyst coverage with Alliance Global setting a $13 price target and Maxim setting a $20 price target, implying substantial upside from the $4.54 share price. Notes innovative intranasal drug delivery platform targeting aggressive brain cancers with significant unmet medical needs. Described as an intriguing speculative opportunity.
Target: $20Horizon: long term
